These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11000987)

  • 1. Clinical use for expanded peripheral blood stem cells.
    Bock TA; Scheding S; Brugger W; Kanz L
    Baillieres Best Pract Res Clin Haematol; 1999; 12(1-2):117-28. PubMed ID: 11000987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo manipulation of hematopoietic stem and progenitor cells.
    Kanz L; Brugger W; Scheding S
    Stem Cells; 1998; 16 Suppl 1():199-204. PubMed ID: 11012163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood stem cell transplantation in breast cancer.
    Shpall EJ; Jones RB; Bearman SI; Cagnoni PJ; Nieto Y; McNiece IK
    Baillieres Best Pract Res Clin Haematol; 1999; 12(1-2):219-32. PubMed ID: 11000995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging.
    Stilz R; Grünebach F; Bader P; Vogel W; Kanz L; Brugger W; Scheding S
    J Hematother Stem Cell Res; 2001 Dec; 10(6):777-85. PubMed ID: 11798504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral Stem Cells in Bone Marrow Transplantation. Future prospects.
    Hui CH; To LB
    Baillieres Best Pract Res Clin Haematol; 1999; 12(1-2):307-18. PubMed ID: 11001001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human bone marrow-derived mesenchymal (stromal) progenitor cells (MPCs) cannot be recovered from peripheral blood progenitor cell collections.
    Lazarus HM; Haynesworth SE; Gerson SL; Caplan AI
    J Hematother; 1997 Oct; 6(5):447-55. PubMed ID: 9368181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo manipulation of hematopoietic stem and progenitor cells.
    Brugger W; Scheding S; Ziegler B; Bühring HJ; Kanz L
    Semin Hematol; 2000 Jan; 37(1 Suppl 2):42-9. PubMed ID: 10718158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD34+ cells can be selected efficiently from cryopreserved peripheral blood progenitor cells and can retain their proliferative potential.
    Alcorn MJ; Holyoake TL; Richmond LJ; Pearson C; Farrell E; Green R; Dunlop DJ; Franklin IM
    J Hematother; 1997 Oct; 6(5):501-10. PubMed ID: 9368187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cellular therapy for intensification in oncology and hematology: manipulation of peripheral blood stem-cell products].
    Douay L
    Bull Cancer; 2001 Sep; 88(9):826-32. PubMed ID: 11604353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum-free ex vivo expansion of CD34(+) hematopoietic progenitor cells.
    Möbest D; Mertelsmann R; Henschler R
    Biotechnol Bioeng; 1998 Nov; 60(3):341-7. PubMed ID: 10099437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive selection of autologous peripheral blood stem cells.
    Lopez M; Beaujean F
    Baillieres Best Pract Res Clin Haematol; 1999; 12(1-2):71-86. PubMed ID: 11000984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy.
    Siena S; Schiavo R; Pedrazzoli P; Carlo-Stella C
    J Clin Oncol; 2000 Mar; 18(6):1360-77. PubMed ID: 10715309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical ex vivo expansion of peripheral blood CD34+ selected cells from cancer patients mobilized with combination chemotherapy and granulocyte colony-stimulating factor.
    Lorenzon D; Mazzucato M; Abbruzzese L; Cilli M; De Angeli S; Degan M; Mambrini G; Piccardi F; Rupolo M; Michieli M; De Marco L; Gattei V; Astori G
    Vox Sang; 2008 May; 94(4):342-50. PubMed ID: 18282263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myeloablative chemotherapy.
    Engelhardt M; Douville J; Behringer D; Jähne A; Smith A; Henschler R; Lange W
    Bone Marrow Transplant; 2001 Feb; 27(3):249-59. PubMed ID: 11277172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large volume ex vivo expansion of CD34-positive hematopoietic progenitor cells for transplantation.
    Purdy MH; Hogan CJ; Hami L; McNiece I; Franklin W; Jones RB; Bearman SI; Berenson RJ; Cagnoni PJ; Heimfeld S
    J Hematother; 1995 Dec; 4(6):515-25. PubMed ID: 8846011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective ex vivo generation of granulopoietic postprogenitor cells from mobilized peripheral blood CD34(+) cells.
    Scheding S; Meister B; Bühring HJ; Baum CM; Mc Kearn JP; Bock T; Kanz L; Brugger W
    Exp Hematol; 2000 Apr; 28(4):460-70. PubMed ID: 10781904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical applications of CD34(+) peripheral blood progenitor cells (PBPC).
    Vogel W; Scheding S; Kanz L; Brugger W
    Stem Cells; 2000; 18(2):87-92. PubMed ID: 10742380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using peripheral blood progenitor cells (PBPC) for transplantation in pediatric patients: a state-of-the-art review.
    Díaz MA; Kanold J; Vicent MG; Halle P; Madero L; Deméocq F
    Bone Marrow Transplant; 2000 Dec; 26(12):1291-8. PubMed ID: 11223968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo expansion of mobilized peripheral blood stem cells.
    Firat H; Douay L
    Baillieres Best Pract Res Clin Haematol; 1999; 12(1-2):99-115. PubMed ID: 11000986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.